Evolv Technologies Holdings, Inc. (EVLV): Nasdaq/NYSE listing notice — Evolv gets Nasdaq delinquency notice for delayed 10-K due to sales probe

Evolv Technologies Holdings, Inc.

Received Nasdaq delinquency notice on Apr 16, 2025 for failing to file 2024 10-K on time.
Delay stems from internal investigation into sales practices affecting revenue recognition and requiring restatement.
Must submit updated compliance plan by May 1, 2025; filing exception runs to May 19, 2025.
Company expects to file both the 10-K and overdue 10-Q simultaneously by May 19, 2025.
No immediate effect on EVLV or EVLVW listing; working with AlixPartners to complete filings.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Evolv Technologies Holdings, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

April 16, 2025, Evolv Technologies Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Nasdaq Listing Rule”) as a result of the delayed filing of the Company’s Annual Report on Form 10-K for the period ended December 31, 2024 (the “Annual Report”). The Company previously submitted a plan to regain compliance with the Nasdaq Listing Rule to Nasdaq in connection with an earlier notice of non-complian

View on SEC.gov

Browse all listing & compliance notices →

Evolv Technologies Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-037530

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.